Please browse these pages to find out more about successful spin-out companies and licensing deals negotiated by Warwick Ventures on behalf of the University of Warwick.
Pioneering hip replacement tool launched in US
Warwick Ventures works closely with academics to ensure that the University’s innovative technologies are protected and made available for companies to license.
Our approach has resulted in some significant successes, including a deal with the international orthopaedic company Voyant Health (now part of Brainlab) to license a measuring device developed in the University’s medical school for use in hip replacement
The device, called KingMark, was developed by Professor Damian Griffin, in the Medical School, along with Richard King, an orthopaedic surgeon at the University Hospital of Coventry and Warwickshire.
It can accurately and non-intrusively measure patients for hip replacements, removing the uncertainty of accurately scaling digital radiograph images.
Warwick Ventures’ Suzanne Evans, who led the negotiations, says:
We filed a patent to protect the IP and then discussed the product with a variety of leading companies working in the orthopaedic field. Voyant Health, immediately saw its immense potential. In partnership with UHCW we negotiated a licence deal through which Voyant Health would develop KingMark and bring it to market and it was great to see this product launched in the US in 2010.”
Richard King shared,
The whole project has been a great experience. As an orthopaedic surgeon, I have relatively little understanding of the business world. Were it not for the involvement of Warwick Ventures, I seriously doubt that KingMark would have gone global.”
Warwick Ventures continues to liaise with Voyant Health and with Professor King, who is already working on a new version of the device.